1. Home
  2. BBIO vs SAIA Comparison

BBIO vs SAIA Comparison

Compare BBIO & SAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • SAIA
  • Stock Information
  • Founded
  • BBIO 2015
  • SAIA 1924
  • Country
  • BBIO United States
  • SAIA United States
  • Employees
  • BBIO N/A
  • SAIA N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • SAIA Trucking Freight/Courier Services
  • Sector
  • BBIO Health Care
  • SAIA Industrials
  • Exchange
  • BBIO Nasdaq
  • SAIA Nasdaq
  • Market Cap
  • BBIO 9.4B
  • SAIA 8.0B
  • IPO Year
  • BBIO 2019
  • SAIA 2002
  • Fundamental
  • Price
  • BBIO $51.21
  • SAIA $312.63
  • Analyst Decision
  • BBIO Strong Buy
  • SAIA Buy
  • Analyst Count
  • BBIO 16
  • SAIA 18
  • Target Price
  • BBIO $64.44
  • SAIA $374.06
  • AVG Volume (30 Days)
  • BBIO 2.2M
  • SAIA 515.9K
  • Earning Date
  • BBIO 11-11-2025
  • SAIA 10-24-2025
  • Dividend Yield
  • BBIO N/A
  • SAIA N/A
  • EPS Growth
  • BBIO N/A
  • SAIA N/A
  • EPS
  • BBIO N/A
  • SAIA 10.83
  • Revenue
  • BBIO $235,812,000.00
  • SAIA $3,235,745,000.00
  • Revenue This Year
  • BBIO $115.49
  • SAIA $2.27
  • Revenue Next Year
  • BBIO $64.61
  • SAIA $6.67
  • P/E Ratio
  • BBIO N/A
  • SAIA $29.16
  • Revenue Growth
  • BBIO 7.62
  • SAIA 4.23
  • 52 Week Low
  • BBIO $21.72
  • SAIA $229.12
  • 52 Week High
  • BBIO $54.60
  • SAIA $624.55
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 52.92
  • SAIA 55.58
  • Support Level
  • BBIO $52.20
  • SAIA $299.50
  • Resistance Level
  • BBIO $54.60
  • SAIA $318.40
  • Average True Range (ATR)
  • BBIO 2.26
  • SAIA 11.00
  • MACD
  • BBIO -0.06
  • SAIA 1.22
  • Stochastic Oscillator
  • BBIO 56.48
  • SAIA 74.30

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

Share on Social Networks: